Association of baseline high-density lipoprotein levels with restenosis after coronary stenting: a meta-analysis

Coron Artery Dis. 2013 Aug;24(5):386-91. doi: 10.1097/MCA.0b013e328362ba8a.

Abstract

Background: Previous studies have reported inconsistent results on the association between serum baseline high-density lipoprotein cholesterol (HDL-C) levels and in-stent restenosis (ISR) after coronary stenting.

Materials and methods: We searched for studies without language restriction in PubMed, Embase, and the Cochrane library before June 2012. Inverse random weighted meta-analysis was carried out using logarithm of the odds ratio of ISR with its SE to assess the strength of association in each study.

Results: Eight observational studies involving 422 ISR and 1113 non-ISR patients were eligible for our analysis. Overall, there was no association between baseline HDL-C levels and ISR (odds ratio: 1.00, 95% confidence interval: 0.96-1.04). The heterogeneity was not significant between individual studies (P=0.074, I=44.0%) and no publication bias was detected. A sensitivity analysis further confirmed the robustness of results. A similar association was detected in the subgroups with bare metal stent and drug-eluting stent implantation.

Conclusion: Our meta-analysis suggests that serum baseline HDL-C levels are not associated with ISR.

Publication types

  • Meta-Analysis
  • Review

MeSH terms

  • Biomarkers / blood
  • Coronary Restenosis / blood
  • Coronary Restenosis / etiology*
  • Drug-Eluting Stents
  • Humans
  • Lipoproteins, HDL / blood*
  • Metals
  • Odds Ratio
  • Percutaneous Coronary Intervention / adverse effects*
  • Percutaneous Coronary Intervention / instrumentation*
  • Prosthesis Design
  • Risk Factors
  • Stents*
  • Treatment Outcome

Substances

  • Biomarkers
  • Lipoproteins, HDL
  • Metals